You've probably heard that if your knees hurt badly enough, you basically have two choices: manage the pain with medication until you can't anymore, or go under the knife for a knee replacement. That's the story most people over 50 have been told, by well-meaning friends and sometimes even by doctors. But studies published in Radiology, the flagship journal of the Radiological Society of North America, in 2025 and 2026 have challenged that story, and a placebo-controlled trial published in 2026 complicates it. Here is what the evidence does and doesn't show.
Myth 1: If You're Not Ready for Surgery, You're Stuck With Pain Pills
This one persists because, for a long time, it was essentially true. Physical therapy, cortisone shots, and anti-inflammatory medications have been the default toolkit for knee osteoarthritis pain relief without surgery. They help some people. They don't help everyone, and they don't help forever.
What has changed is that a catheter-based procedure called genicular artery embolization (GAE, for short) has now been studied in larger groups of patients. The July 2025 Radiology study followed patients with symptomatic knee osteoarthritis for a year. Of 333 patients treated, 272 were checked at 12 months, and the study reported lasting pain relief and better function and quality of life over that year. That study had no comparison group, though. A 2026 randomized trial in European Radiology compared GAE with a sham (placebo) procedure in 58 people with mild to moderate knee osteoarthritis. After 12 months, pain had improved in both groups, with no significant difference between them. The researchers concluded that pain relief after GAE “appears mainly placebo-driven” and that their results do not support offering GAE as a treatment for knee osteoarthritis.
The procedure works by targeting the abnormal blood vessels that feed chronic inflammation in an arthritic knee. A radiologist threads a tiny catheter through a small nick in the skin (usually at the wrist or groin) and delivers microscopic beads that partially block those vessels. The idea is that as inflammation drops, pain drops with it, although the sham-controlled trial found no reduction in joint inflammation on MRI.
Myth 2: "Minimally Invasive" Just Means a Smaller Scar
When people hear "minimally invasive," they often picture standard surgery with a shorter incision. GAE is something else entirely: there's no cutting into the joint, no general anesthesia in most cases, no bone sawing, no implants, and no weeks in a rehabilitation facility afterward.
Most patients go home the same day. Recovery discomfort is typically described as mild. It is not risk-free, though. In a 2026 Radiology study of 194 people who had 239 GAE procedures, temporary skin discoloration occurred after 6.3% of procedures, and one person developed a small collection of blood (hematoma) near the groin puncture site. All of these cleared up, and there were no moderate or severe complications. Compare that to total knee replacement, which involves hospitalization, significant post-operative pain management, and a rehabilitation process that can stretch over several months, with no guarantee the outcome will meet expectations.
That distinction matters enormously for the 50+ adults who are either not medically suitable for major surgery or who aren't ready to commit to it. The Society of Interventional Radiology's 2026 position statement describes GAE as a targeted, joint-preserving option and reviews its evidence, safety and regulatory status. That's a professional society formally weighing in on the procedure.
Myth 3: GAE Is Mainly for Badly Worn Knees
GAE is usually offered to people whose knee pain has not improved with medications, injections or physical therapy, and who aren't candidates for knee replacement surgery or don't want it. These patients have more than occasional stiffness: their pain is affecting sleep, mobility, and daily function. But that doesn't mean the most damaged knees do best.
In a UCLA retrospective study of 236 knee osteoarthritis patients, about half (54%) had a successful result at one year. Results were better in younger patients and in those with mild-to-moderate osteoarthritis than in those with more advanced joint damage, and the authors suggested earlier treatment may be appropriate. Keep in mind that the sham-controlled trial above also enrolled people with mild to moderate osteoarthritis and found no clear benefit over placebo, so the question of who gains the most is still open.
Of course, GAE isn't for everyone. Your doctor needs to confirm that abnormal neovascularization (that overgrowth of blood vessels) is present and contributing to your symptoms. Imaging and clinical evaluation matter here.
Myth 4: One Study Doesn't Really Change Anything
Fair skepticism. Medical history is full of procedures that looked promising in small studies and faded when larger trials ran. The July 2025 Radiology study reported lasting relief, but like most GAE studies it had no placebo group, and the one sham-controlled trial with 12-month results found no clear benefit over placebo.
Larger placebo-controlled trials are what would settle the question. The Society of Interventional Radiology's position statement arrived the same year, and it's the kind of document that hospital systems and insurers read when they're deciding what to cover.
For patients, this shift has a practical implication: having a conversation with an interventional radiologist is becoming a more realistic option, not a long-shot request.
Myth 5: If It Worked, Your Doctor Would Have Told You Already
This is probably the most frustrating myth, because it's nobody's fault, yet it does real harm. Primary care physicians and orthopedic surgeons are extraordinarily busy. Many trained during a period when GAE wasn't on the menu. The procedure is performed by interventional radiologists, a specialty that most patients never encounter unless they're referred for a specific imaging-guided treatment.
The referral pathway for GAE doesn't always flow naturally from a primary care visit or an orthopedic consultation focused on surgical options. That means patients who might benefit are sometimes not hearing about it. The usual reason is a medical system siloed in ways that don't always serve patients well, rather than a doctor withholding information.
In practice, you may need to ask directly. You can ask your doctor whether a referral to an interventional radiologist for evaluation would be appropriate. Bring up the studies above, including the sham-controlled trial, so you can talk through both sides. Advocating for yourself in a medical conversation is always reasonable.
What to Do While You're Exploring Your Options
Waiting for a specialist appointment doesn't mean sitting still. Gentle movement, weight management, and stress reduction all have documented effects on osteoarthritis symptoms, and the cognitive-physical connection is real. Chronic pain has a measurable impact on mental sharpness, and staying mentally engaged matters.
If you have SteadiDay Premium, the Mind Breaks games are worth keeping in your daily routine during this period. Short, engaging cognitive games help counteract the mental fatigue that often accompanies chronic pain, and they take less than five minutes. Small daily habits add up, especially when you're managing something as persistent as knee osteoarthritis.
On the physical side, low-impact movement such as water aerobics, cycling, and resistance band exercises can help preserve muscle strength around the knee joint without aggravating cartilage. Talk to your care team about what's appropriate for your specific situation.
Where This Leaves You
GAE is a real option with a growing evidence base and 12-month results in hundreds of patients, but the evidence is mixed. The one sham-controlled trial with 12-month results found that people did about as well after a placebo procedure, which suggests much of the benefit may come from the placebo effect. It's not right for everyone, it carries small risks, and it doesn't replace a thorough medical evaluation. If you've been told that surgery is your only meaningful option, and you're not ready for that or your doctor has said you're not a good candidate, it's still a conversation worth having. Ask about it, weigh the mixed evidence with your doctor, and decide together whether a referral makes sense.
Common Questions
What is genicular artery embolization, and is it considered a surgical procedure?
Genicular artery embolization (GAE) is a minimally invasive, catheter-based procedure performed by an interventional radiologist. A thin catheter is inserted through a small skin puncture rather than a surgical incision, and tiny beads are used to reduce blood flow to inflamed tissue around the knee. It does not involve cutting into the joint, placing implants, or general anesthesia, and most patients return home the same day.
Who is a good candidate for GAE as a knee osteoarthritis treatment?
GAE is typically considered for adults with symptomatic knee osteoarthritis who have tried and not gotten adequate relief from conservative treatments like physical therapy, medications, or steroid injections, and who either are not candidates for total knee replacement or wish to delay it. A UCLA study found that patients at earlier stages of osteoarthritis tend to have better outcomes, so it may be worth asking about sooner rather than later. An interventional radiologist can evaluate whether the pattern of blood vessel overgrowth associated with GAE candidacy is present.
Does insurance cover genicular artery embolization for knee osteoarthritis?
Coverage varies by insurer and is evolving. The 2026 Society of Interventional Radiology position statement and the July 2025 Radiology study are the kind of evidence that insurers and hospital systems use when reviewing coverage decisions. For now, it's worth contacting your insurer directly and asking your interventional radiologist's office whether they can assist with prior authorization.
How long does pain relief from GAE last for knee osteoarthritis patients?
A study published in Radiology in July 2025 reported lasting pain relief and better function over 12 months of follow-up. A smaller sham-controlled trial found similar 12-month improvement after a placebo procedure, so how much of the relief comes from GAE itself is uncertain. Longer-term data beyond 12 months is still accumulating.
Updated November 15, 2026: We added a 2026 sham-controlled trial that found no clear benefit of GAE over a placebo procedure, added the procedure's known risks, corrected Myth 3 (results were better in mild-to-moderate osteoarthritis, not advanced disease), and removed claims we could not source. We also removed a "largest study" claim for the July 2025 Radiology study, and later restored its patient counts (333 treated, 272 checked at 12 months) after confirming them with the journal.
Sources
This article draws on the sources below. Each entry shows the passage it supports.
- RSNA: “July 2025 Radiology study”
- PubMed: “2026 randomized trial in European Radiology”
- PubMed: “2026 Radiology study of 194 people”
- Journal of Vascular and Interventional Radiology: “Society of Interventional Radiology's 2026 position statement”
- NCBI (NIH): “UCLA retrospective study of 236 knee osteoarthritis patients”
SteadiDay for iPhone
Emergency SOS, fall detection and medication reminders are free, with no card to enter. Premium adds Share Activity for caregivers, Apple Health and the wellness tools.
Download on the App Store